Aspen Aerogels (NYSE:ASPN) Upgraded to Sell at StockNews.com

Aspen Aerogels (NYSE:ASPN) was upgraded by analysts at StockNews.com to a “sell” rating in a research note issued to investors on Saturday.

Other analysts have also issued reports about the company. Barclays lowered their target price on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 12th. Piper Sandler dropped their price objective on shares of Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Roth Mkm cut their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. Canaccord Genuity Group lowered their price target on shares of Aspen Aerogels from $28.00 to $20.00 and set a “buy” rating on the stock in a research report on Thursday, January 16th. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $30.00 price objective on shares of Aspen Aerogels in a report on Wednesday, October 16th. One investment analyst has rated the stock with a sell rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Aspen Aerogels has a consensus rating of “Moderate Buy” and a consensus price target of $29.11.

Aspen Aerogels Trading Down 1.2 %

NYSE:ASPN opened at $11.49 on Friday. Aspen Aerogels has a 12 month low of $10.67 and a 12 month high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The firm’s 50 day moving average is $12.57 and its 200 day moving average is $18.96. The stock has a market capitalization of $942.34 million, a PE ratio of 1,149.65 and a beta of 2.14.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Lord Abbett & CO. LLC purchased a new stake in shares of Aspen Aerogels in the third quarter worth $10,126,000. Oppenheimer & Co. Inc. raised its holdings in shares of Aspen Aerogels by 167.2% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company’s stock valued at $2,839,000 after acquiring an additional 64,154 shares in the last quarter. Sanders Morris Harris LLC boosted its position in shares of Aspen Aerogels by 337.5% during the 4th quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company’s stock valued at $436,000 after acquiring an additional 27,000 shares during the last quarter. Penserra Capital Management LLC bought a new stake in shares of Aspen Aerogels during the 3rd quarter valued at about $1,342,000. Finally, Geode Capital Management LLC grew its holdings in shares of Aspen Aerogels by 5.7% during the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company’s stock worth $38,385,000 after purchasing an additional 75,024 shares in the last quarter. 97.64% of the stock is owned by institutional investors.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.